Published in Lab Business Week, January 16th, 2005
Bentley's business generates revenues through manufacturing and marketing of branded pharmaceuticals, generic pharmaceuticals, licensing and supply collaborations with other pharmaceutical companies and export sales to customers, primarily in Europe.
It also receives royalties from Auxilium Pharmaceuticals, Inc., (AUXL), based upon sales of its Testim testosterone gel, and it has recently signed a collaboration agreement with Perrigo Co. (PRGO) for the introduction of products into the United States.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-01-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.